Navigation Links
GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)
Date:5/16/2008

Highlights Include:

-- Results demonstrating that TYKERB and trastuzumab together resulted in a clinically meaningful extension of progression-free survival (PFS)

-- Combining TYKERB and trastuzumab to attack both the inside and outside of the HER2 receptor may create a more complete HER2 blockade

-- Data demonstrating activity of TYKERB alone despite patients' previous treatment with multiple lines of trastuzumab and chemotherapy

LONDON and PHILADELPHIA, May 16 /PRNewswire-USNewswire/ -- GlaxoSmithKline today announced positive data from the first-ever randomized, multi-center, open label Phase III trial of the combination of two targeted agents, TYKERB and trastuzumab, in women with HER2-positive metastatic breast cancer (1). HER2-positive breast cancer is a particularly aggressive form of cancer that affects approximately 25 to 30 percent of breast cancer patients (2). The study results demonstrated a benefit from the combination. Both treatments target the HER2 (ErbB2) protein but work in different ways (1). Trastuzumab attaches to the outside of the HER2 protein, while TYKERB goes inside the cell to block signals from the HER2 protein for the cancer to grow (3). GlaxoSmithKline Oncology will present these and other new data in breast cancer at the annual American Society of Clinical Oncology (ASCO) meeting in Chicago beginning Friday, May 30th.

"Many women with HER2 positive breast cancer are still very active and living full lives, yet when their disease progresses after trastuzumab and chemotherapy, we have had limited treatment options. Therefore it is important to study options that may eventually help women in their fight against this disease," said lead investigator Joyce O'Shaughnessy, M.D., Baylor-Sammons Cancer Center, Texas Oncology, PA, US Oncology, Dallas, TX. "Effectively attacking HER2 from multiple angles is an exciting and innovative approach, and demonstrates the significant advances being achieved in t
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
2. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
3. BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting
4. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
5. Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
6. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
7. Kosan Announces Data Presentations at ASCO 2008 Annual Meeting
8. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
9. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
10. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
11. Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015  Health Catalyst, ... analytics, today launched Health Catalyst Academy ... help health systems build the internal capacity ... operational efficiency. Health Catalyst ... Catalyst,s comprehensive suite of outcomes-improvement solutions and ...
(Date:5/26/2015)... May 26, 2015  PAREXEL International Corporation (NASDAQ: ... at the Goldman Sachs Healthcare Conference in Palos Verdes, ... Executive Officer, will be making a presentation on PAREXEL ... Tuesday, June 9, 2015. A live webcast ... section of PAREXEL,s website at www.PAREXEL.com in ...
(Date:5/26/2015)...  Halyard Health, Inc. (NYSE: HYH ) today announced ... will present at the 2015 Morgan Stanley Leveraged Finance Conference ... a.m., CDT on Thursday, June 4. A webcast ... section of the Halyard Health website at https://halyardhealth.investorroom.com/ ... About Halyard Health: Halyard Health (NYSE: HYH ...
Breaking Medicine Technology:Introducing Health Catalyst Academy: An Innovative Approach for Accelerating Outcomes Improvement 2Introducing Health Catalyst Academy: An Innovative Approach for Accelerating Outcomes Improvement 3Introducing Health Catalyst Academy: An Innovative Approach for Accelerating Outcomes Improvement 4PAREXEL International To Present At Goldman Sachs Healthcare Conference 2
... announces that a new market research report is ... Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies) ... Drug delivery is evolving at a rapid rate ... Advanced drug delivery deals with developing solutions for ...
... Reportlinker.com announces that a new market research ... France Pharmaceutical Market Overview – Austerity measures ... http://www.reportlinker.com/p0360215/France-Pharmaceutical-Market-Overview-–--Austerity-measures-will-impact-pharmaceutical-market-growth.html Introduction ... France was valued at $38.8bn in sales in ...
Cached Medicine Technology:Reportlinker Adds Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies) 2Reportlinker Adds Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies) 3Reportlinker Adds France Pharmaceutical Market Overview - Austerity measures will impact pharmaceutical market growth 2
(Date:5/27/2015)... The Case Management Society of America has ... Lifetime Achievement Award, to Anne Llewellyn RN-BC, MS, BHSA, ... at the association’s 25th Annual Conference and Expo at ... CMSA Board of Directors awards the Lifetime Achievement Award ... contribution to practice of case management and in support ...
(Date:5/27/2015)... May 27, 2015 Water, ... water filtration products, has announced that its elite ... of the first to pass the new NSF/ANSI ... certification is monumental, proving that the BG-12000 by ... pharmaceuticals, over-the-counter medications, and chemicals used in manufacturing ...
(Date:5/27/2015)... One of America's most cherished actors, James Earl Jones, ... takes a look at the topic of atrial fibrillation. ... heart rhythm. Those who suffer from atrial fibrillation have ... quickly. , This new segment will take a look ... inform viewers about possible signs that commonly indicate the ...
(Date:5/27/2015)... 27, 2015 HomeTown Health, along with ... north Georgia cities on May 13 & 14. In ... physicians to meet with the group of representatives and ... and office staff attended. , Referred to as ... to bring together Health Information Technology and ICD-10 resources ...
(Date:5/26/2015)... In celebration of Parker and Sons forty years of ... HVAC systems with a high Season Energy Efficiency Rating (SEER) ... a SEER rating around 15-16 can be purchased for under ... with a SEER rating, it is essentially what miles per ... amount of energy expended by the actual heating and cooling ...
Breaking Medicine News(10 mins):Health News:CMSA to Present Prestigious Lifetime Achievement Award to Anne Llewellyn RN-BC, MS, BHSA, CCM, CRRN 2Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 2Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 3Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 2Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 3Health News:Parker and Sons Recounts its Path to Success 2
... Aug. 17 Hypertronics C ... of high performance interconnect solutions for the most demanding applications ... by Biosense Webster, Inc. for its new CARTO((R)) 3 Navigation ... signal reliability and ease of use as a push pull ...
... Trust for America,s Health (TFAH) applauds six of the nation,s ... a central part of health reform. , ... Robert Wood Johnson Foundation, W.K. Kellogg Foundation, and Kaiser Permanente ... focus on community prevention will improve health, save money, reduce ...
... as a group have lower rates of thinking about ... women seem to be particularly at risk for suicidal ... study shows 15.93 percent of U.S.-born Asian-American women have ... 13.5 percent for all Americans. The finding comes ...
... N.J., Aug. 17 Wyeth (NYSE: WYE ) (the ... of all of its outstanding Wyeth Floating Rate Convertible Senior Debentures ... of August 14, 2009, there was $22,664,000 in aggregate principal amount ... will be redeemed by the Company at a cash purchase price ...
... , , , ... WASHINGTON, Aug. 17 With two storms swirling ... people who live in hurricane-prone areas to update their preparedness plans. ... "Just this weekend Tropical Storm Claudette formed very quickly in the ...
... , ST. PAUL, Minn., Aug. ... particle pollution like smoke and smog, as well as other ... airborne contaminants to experience shortness of breath, wheezing and coughing, ... According to AIRNow.gov(2), a government-developed index for reporting daily air ...
Cached Medicine News:Health News:Hypertronics Circular HyperGrip(R) Connectors Selected for Biosense Webster's CARTO(R) 3 Navigation System 2Health News:Trust for America's Health Praises Major Foundations for Supporting Prevention as a Central Part of Health Reform 2Health News:US-born Asian-American women more likely to think about, attempt suicide 2Health News:US-born Asian-American women more likely to think about, attempt suicide 3Health News:Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 2Health News:Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 3Health News:Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 4Health News:Hurricane Season Heats Up 2Health News:Hurricane Season Heats Up 3Health News:Bad Air Day Alert: Outdoor Air Pollutants at High Level 2Health News:Bad Air Day Alert: Outdoor Air Pollutants at High Level 3
Long handle occluders are approximately 9 inches long....
Manual Lensmeter....
Lightweight, cordless lensmeter....
Lightweight, cordless lensmeter....
Medicine Products: